MCM
MDCX

Marathon Capital Management’s Medicus Pharma MDCX Stock Holding History

Marathon Capital Management’s Portfolio MDCX Stock Details MDCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.92K Hold
15,500
– – ﹤0.01% 186
2026
Q1 		$7.12K Buy
+15,500
New +$16.2K ﹤0.01% 170

Other funds holding MDCX

ICP
Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $479M AUM 31.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return

Marathon Capital Management's MDCX Position: Q2 2026 in Review

Marathon Capital Management held its Medicus Pharma (MDCX) position steady in Q2 2026 at 15,500 shares worth $6.92K. The position accounts for ﹤0.01% of the portfolio, ranked #186.

Marathon Capital Management first reported a position in MDCX in Q1 2026 and has held it in 2 quarters since. The position peaked at $7.12K in Q1 2026. 23 funds tracked by Wall St. Rank hold MDCX as of Q2 2026.

  • Marathon Capital Management held 15,500 shares of Medicus Pharma worth $6.92K as of Q2 2026.
  • Marathon Capital Management left its Medicus Pharma share count unchanged in Q2 2026.
  • Medicus Pharma made up ﹤0.01% of Marathon Capital Management's portfolio in Q2 2026, its #186 holding.
  • Marathon Capital Management first reported a position in Medicus Pharma in Q1 2026 and has held it in 2 quarters since.
  • Marathon Capital Management's Medicus Pharma position peaked at $7.12K in Q1 2026.
  • 23 funds tracked by Wall St. Rank held Medicus Pharma as of Q2 2026.

Based on Marathon Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.